1249. Metabolomic Profile of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) in Latin-American MRSA Isolates

BACKGROUND: Vancomycin (VAN) is a first-line therapeutic option in severe infections caused by MRSA in Latin-America (LA). Development of reduced susceptibility to VAN has been associated with multiple changes in genes encoding pathways for cell wall metabolism and envelope stress responses. Neverth...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro-Cardozo, Betsy E, Cala, Monica, Espitia-Acero, Catalina, Rios, Rafael, Leon, Lizeth, Arias, Cesar A, Rincon, Sandra, Reyes, Jinnethe, Diaz, Lorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644742/
http://dx.doi.org/10.1093/ofid/ofab466.1441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644742/
http://dx.doi.org/10.1093/ofid/ofab466.1441

Ejemplares similares